The Scientist

» clinical trials and microbiology

Most Recent

image: Opinion: A Mother’s Microbes

Opinion: A Mother’s Microbes

By | March 3, 2016

On “vaginal seeding” and the challenge of evidence-based parenting

0 Comments

image: Amoebae Have Human-Like Immunity

Amoebae Have Human-Like Immunity

By | March 2, 2016

Dictyostelium discoideum produce extracellular nets that can kill bacteria, just as phagocytes in people and other higher animals do, according to a study.

0 Comments

image: Giant Virus Has CRISPR-like Immune Defense

Giant Virus Has CRISPR-like Immune Defense

By | March 2, 2016

The genome of a mimivirus strain resistant to a virophage has repeated phage sequences alongside nuclease- and helicase-coding sections.

1 Comment

image: Desperately Seeking Shut-Eye

Desperately Seeking Shut-Eye

By | March 1, 2016

New insomnia drugs are coming on the market, but drug-free therapy remains the most durable treatment.

0 Comments

image: Spoiler Alert

Spoiler Alert

By | March 1, 2016

How to store microbiome samples without losing or altering diversity

1 Comment

image: Cautious Optimism About ZMapp Trial

Cautious Optimism About ZMapp Trial

By | February 25, 2016

The Ebola drug increased survival in a small study, but the effect was not statistically significant.

0 Comments

image: Opinion: Why Most TBI Studies Fail

Opinion: Why Most TBI Studies Fail

By | February 24, 2016

Thoughts on how to redesign clinical trials for traumatic brain injury

1 Comment

image: Similar Data, Different Conclusions

Similar Data, Different Conclusions

By | February 23, 2016

By tweaking certain conditions of a long-running experiment on E. coli, scientists found that some bacteria could be prompted to express a mutant phenotype sooner, without the “generation of new genetic information.” The resulting debate—whether the data support evolutionary theory—is more about semantics than science.

0 Comments

image: Breast Milk Sugars Support Infant Gut Health

Breast Milk Sugars Support Infant Gut Health

By | February 18, 2016

Oligosaccharides found in breast milk stimulate the activity of gut bacteria, promoting growth in two animal models of infant malnutrition.

0 Comments

image: In Situ Antibodies

In Situ Antibodies

By | February 2, 2016

Compared with systemic injections, localized antibody therapies may be more effective for some indications.

2 Comments

Advertisement
QIAGEN ingenuity
QIAGEN ingenuity

Popular Now

  1. Antibody Maker Loses License Over Animal Welfare Violations
  2. ORI: Researcher Faked Dozens of Experiments
    The Nutshell ORI: Researcher Faked Dozens of Experiments

    A former scientist at the University of Michigan and the University of Chicago made up more than 70 experiments on heart cells, according to the Office of Research Integrity.

  3. Exploring Emotional Contagion
  4. Immune Defect Detected in Knockout Mice
Advertisement
LabX
LabX
Advertisement
LabX
LabX
Biosearch Technologies
illumina Corporate
illumina Corporate